Biology of secondary leukemia
Common mutations in de novo and secondary AML. A number of clonal blood... | Download Scientific Diagram
Key Topic Videos | MYLOTARG®▽(gemtuzumab ozogamicin) | PfizerPro UK
Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst - ScienceDirect
Outcome of patients with either de novo or secondary AML after alloSCT... | Download Scientific Diagram
Genes | Free Full-Text | Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia
Acute Myeloid Leukemia | Oncohema Key
Recently approved therapies in acute myeloid leukemia: A complex treatment landscape - ScienceDirect
Personalizing initial therapy in acute myeloid leukemia: incorporating novel agents into clinical practice - Christin B. DeStefano, Christopher S. Hourigan, 2018
High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study | Blood Cancer Journal
Venetoclax plus intensive induction chemotherapy safe for fit, older patients with AML
A) Incidence of De Novo, Secondary, and Therapy-Related Acute Myeloid... | Download Scientific Diagram
SocforHemepath on Twitter: "Another new provisional entity in the 2017 WHO: Acute Myeloid Leukemia with BCR-ABL1. This is a type of de novo AML, not to be confused with the blast phase
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1 - Modern Pathology
How do doctors tell de novo acute myeloid leukemia (de novo AML), AML-MRC, and tAML apart? - YouTube
Secondary acute myeloid leukemia
AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics | Leukemia
Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities | Haematologica
Haematologica August 2021
What is AML? | MDS Foundation
Diagnosis and treatment of therapy-related acute myeloid leukemia - ScienceDirect
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research
